Robert Huffines

Robert Huffines
Global Chairman of Investment Banking at J.P. Morgan

Robert Huffines

Mr. Huffines is member of the board of directors for Solid Biosciences

Mr. Huffines joined J.P. Morgan in 1991 and is currently Global Chairman of Investment Banking. Starting in the Mergers and Acquisitions group, where he was healthcare focused, Mr. Huffines was Co-Head of the Global Healthcare Investment Banking Group from 2002 – 2010 and promoted to Vice Chairman in 2011. 

Mr. Huffines has advised numerous healthcare companies on strategic transactions including J&J’s sale of Ortho Clinical Diagnostics (pending); Thermo Fisher’s acquisition of Life Technologies, Kinetic Concepts go-private; Sanofi-Aventis on its acquisition of Genzyme; Merck’s acquisition of Schering Plough; Guidant’s sale to Boston Scientific and Abbott; Bristol-Myers Squibb’s acquisition of Medarex; Celgene’s acquisition of Pharmion; Kinetic Concept’s acquisition of LifeCell, Amgen’s acquisition of Mustafa Nevzat and sale of Amgen K.K. to Takeda; Eisai’s acquisition of MGI Pharmaceuticals; Merck’s acquisition of Banyu Pharmaceuticals and divestiture of Medco Health Solutions; Bristol-Myers Squibb’s divestitures of Medical Imaging, Zimmer, and Mead Johnson and acquisition of Dupont Pharmaceuticals; Guidant’s acquisition of CardioThoracic Systems and Cook (withdrawn); Sofamor Danek’s sale to Medtronic; and Johnson & Johnson’s acquisitions of Mitek, Cordis, and Neutrogena and sale of Janssen Annual Health.

At J.P. Morgan, Mr. Huffines has extensive experience financing healthcare companies. Prior to joining J.P. Morgan, Mr. Huffines worked at Alex Brown & Sons, specializing in equity financings and advisory assignments for emerging growth companies. Mr. Huffines has an MBA degree from the University of Virginia, where he received the Faculty Award for academic excellence. He has a B.A. degree from the University of North Carolina, where he majored in English and Economics. Mr. Huffines is married and has four children.

His volunteer work includes The Brookings/Gates Global Health Innovative Financing Advisory Group, the Student Sponsor Partnership, a member of the Corporate Advisory Board at the Darden School, and serving as a Board Member of the Spence School.